Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma
The anaphase-promoting complex (ANAPC) plays a critical role in tumor cell mitosis. Constructing an ANAPC-related prognostic signature may aid hepatocellular carcinoma (HCC) patient stratification, treatment selection, and follow-up optimization. Transcriptional profiles and clinical data of HCC samples were retrieved from The Cancer Genome Atlas (TCGA). We developed a risk scoring system based on a machine learning algorithm. Moreover, we investigated the oncogenic function of CDC27 in Huh-7 cells. We profiled ANAPC expression, genomic alterations, and prognostic associations in HCC. Patients were stratified into two subgroups with distinct prognostic outcomes based on ANAPC-gene expression. An ANAPC-cluster-derived prognostic signature comprising SPP1, CDCA8 and CFHR4 was subsequently built. The risk score separated high- and low-risk patients with differences in survival, immune-checkpoint expression, immune-cell infiltration, and computationally inferred immunotherapy and drug-sensitivity responses. In vitro assays showed that CDC27 knockdown suppresses proliferation and invasion in Huh-7 cells. In conclusion, we constructed an ANAPC-associated prognostic signature with promising predictive performance for HCC survival, tumor microenvironment, computationally predicted immunotherapy response and drug sensitivity. Our in-vitro data support the oncogenic role of CDC27 in Huh-7 HCC cells.
Authors
- shousheng Liu
- Kunwei Peng (ORCID: https://orcid.org/0000-0003-4494-8154)
- Li Liao
- Jiaxin Yang
- Cuirong Tan
- Haoqian Song
Institutions
- Sun Yat-sen University (CN)
- Guangdong Medical College (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12885-026-17420-1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00